Skip to content

Evaluation of the effectiveness of women's empowerment in predicting infected COVID-19 outcomes.

The effect of a web-based education strategy on immunoglobulin G and M in the prevention of covid-19

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT20221228056969N1
Enrollment
303
Registered
2023-01-21
Start date
2020-12-31
Completion date
Unknown
Last updated
2023-02-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

COVID-19. Coronavirus as the cause of diseases classified elsewhere

Interventions

Intervention 1: Intervention group: The current study aimed to provide four education sessions on mental health behavior and four training sessions on personal health behaviors, Physical activity, and

Sponsors

WHO Eastern Mediterranean Regional Office
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
30 Years to 60 Years

Inclusion criteria

Inclusion criteria: Housewives with an age range of 30-60years No renal disease or diabetes, mental and learning problems, vision, and hearing problems Has literacy Internet access Having a computer or smartphone

Exclusion criteria

Exclusion criteria: Pregnant women / intention to conceive or breastfeed Subjects with COVID-19 disease Subjects who are recovering of COVID-19

Design outcomes

Primary

MeasureTime frame
Immunoglobulin G (IgG) and Immunoglobulin M (Ig M) antibodies titers. Timepoint: This study was conducted at three time points: baseline, post-intervention (4 weeks), and follow-up (12 weeks). Method of measurement: enzyme-linked immunosorbent assay, using kits (ELISA; Pishtaz, Iran).

Secondary

MeasureTime frame
Symptoms of COVID-19 Diseases. Timepoint: baseline, post-intervention (4 weeks), and follow-up (12 weeks). Method of measurement: the physician examined the participants' physical condition during the study and diagnosed symptoms of COVID-19 diseases.;Mental Health Behavior score. Timepoint: baseline, post-intervention (4 weeks), and follow-up (12 weeks). Method of measurement: the lifestyle for prevention of infectious diseases questionnaire (LSPIDQ).;Stress and Anxiety score. Timepoint: baseline, post-intervention (4 weeks), and follow-up (12 weeks). Method of measurement: the lifestyle for prevention of infectious diseases questionnaire (LSPIDQ).;Personal and Public Health Behavior score. Timepoint: baseline, post-intervention (4 weeks), and follow-up (12 weeks). Method of measurement: the lifestyle for prevention of infectious diseases questionnaire (LSPIDQ).;Physical activity behavior score. Timepoint: baseline, post-intervention (4 weeks), and follow-up (12 weeks). Method of measurement: the lifestyle for prevention of infectious diseases questionnaire (LSPIDQ).;Healthy eating behavior score. Timepoint: baseline, post-intervention (4 weeks), and follow-up (12 weeks). Method of measurement: the lifestyle for prevention of infectious diseases questionnaire (LSPIDQ).;Average intake of macronutrients. Timepoint: baseline, post-intervention (4 weeks), and follow-up (12 weeks). Method of measurement: 24-hour dietary recall.;Physical activity score. Timepoint: baseline, post-intervention (4 weeks), and follow-up (12 weeks). Method of measurement: the International Physical Activity Questionnaire (IPAQ).

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMaryam Zare

Ardabil University of Medical Sciences

zaremaryam119@gmail.com+98 45 3352 2247

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026